Vedolizumab-4018: Observational Study of the Effectiveness of Vedolizumab on Treatment Outcomes and HRQoL in biologic naïve Patients with Inflammatory Bowel Diseases in Greece (TROVE)

11/05/2018
30/10/2025
EU PAS number:
EUPAS23580
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Vedolizumab-4018-clinical-study-protocol-redact.pdf

English (3.34 MB - PDF) View document
Study results
Study results

Vedolizumab-4018-clinical-study-report-redact.pdf

English (956.67 KB - PDF) View document
Study report
Other information